AMA, AARP Back FTC In Pay-For-Delay Antitrust Fight
The American Medical Association, AARP and others on Tuesday backed the Federal Trade Commission's bid to overturn a ruling holding so-called pay-for-delay pharmaceutical patent settlements to be legal, warning the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article